Stay updated on ALT-801 NK Cells After FLAG Induction Clinical Trial
Sign up to get notified when there's something new on the ALT-801 NK Cells After FLAG Induction Clinical Trial page.

Latest updates to the ALT-801 NK Cells After FLAG Induction Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now uses a general 'Locations' section including Texas, replacing the former 'Texas Locations' heading; the 'HHS Vulnerability Disclosure' link has been removed.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this appears to be a minor update that does not affect study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoved the notice about government funding and operating status. This does not alter the trial details, eligibility criteria, or contacts on the page.SummaryDifference0.4%

- Check59 days agoChange DetectedThe screenshots indicate minor visual and formatting updates to the study page with no changes to core study details such as eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check87 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check95 days agoChange DetectedVersion metadata updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to ALT-801 NK Cells After FLAG Induction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 NK Cells After FLAG Induction Clinical Trial page.